Next Article in Journal
Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?
Previous Article in Journal
Effect of Transcranial Direct Current Stimulation on Memory and Emotional Recovery in Patients with Stroke and Traumatic Brain Injury: A Prospective, Multicenter, Interventional Pilot Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exploring Coronavirus Disease 2019 Risk Factors: A Text Network Analysis Approach

1
Department of Nursing, Keimyung College University, Daegu 42601, Republic of Korea
2
Department of Medical Informatics, College of Nursing & Health, Kongju National University, Kongju 32588, Republic of Korea
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(6), 2084; https://doi.org/10.3390/jcm14062084
Submission received: 15 February 2025 / Revised: 8 March 2025 / Accepted: 11 March 2025 / Published: 19 March 2025
(This article belongs to the Section Epidemiology & Public Health)

Abstract

:
Background/Objectives: The coronavirus disease 2019 (COVID-19) pandemic has significantly affected global health, economies, and societies, necessitating a deeper understanding of the factors influencing its spread and severity. Methods: This study employed text network analysis to examine relationships among various risk factors associated with severe COVID-19. Analyzing a dataset of published studies from January 2020 to December 2021, this study identifies key determinants, including age, hypertension, and pre-existing health conditions, while uncovering their interconnections. Results: The analysis reveals five thematic clusters: biomedical, occupational, demographic, behavioral, and complication-related factors. Temporal trend analysis reveals distinct shifts in research focus over time. In early 2020, studies primarily addressed immediate clinical characteristics and acute complications of COVID-19. By mid-2021, research increasingly emphasized long COVID, highlighting its prolonged symptoms and impact on quality of life. Concurrently, vaccine efficacy became a dominant topic, with studies assessing protection rates against emerging viral variants, such as Alpha, Delta, and Omicron. This evolving landscape underscores the dynamic nature of COVID-19 research and the adaptation of public health strategies accordingly. Conclusions: These findings offer valuable insights for targeted public health interventions, emphasizing the need for tailored strategies to mitigate severe outcomes in high-risk groups. This study demonstrates the potential of text network analysis as a robust tool for synthesizing complex datasets and informing evidence-based decision-making in pandemic preparedness and response.

1. Introduction

The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted global health systems, economies, and societies. While the acute phase of the pandemic has passed, COVID-19 continues to pose significant health challenges, including the emergence of new variants, long-term complications (long COVID), and mental health effects [1,2]. These ongoing concerns underscore the necessity of continued research on risk factors associated with COVID-19 severity and outcomes. As of December 2021, the long-term effects of COVID-19 and its impact on various populations remain insufficiently understood, necessitating further investigation.
COVID-19′s high transmissibility and variable severity have driven extensive research into its biological, environmental, and social determinants. Early studies highlighted age, comorbidities, and socioeconomic status as key risk factors [2]. However, while these studies provided valuable insights, they often relied on traditional epidemiological models that struggled to capture the evolving and interconnected nature of these risks. Additionally, prior studies often examined risk factors in isolation, lacking a holistic perspective on how different factors interact within the broader research landscape.
The evolving characteristics of COVID-19 have revealed significant disparities in outcomes based on demographic features such as age, sex, race, and socioeconomic status. Studies have shown that older adults and individuals with pre-existing conditions face higher risks of severe illness, while marginalized communities experience disproportionate effects due to limited healthcare access and economic constraints [3]. Variations in health policies, preventive measures, and vaccine distribution add to the complexity of global responses [4]. Addressing these challenges requires advanced analytical approaches that synthesize vast amounts of data to reveal underlying patterns across diverse datasets.
To address these challenges, researchers increasingly turn to computational and data-driven approaches [5]. Advances in data analytics and computational modeling have enabled new approaches, particularly text network analysis, which has emerged as an effective method for identifying patterns and associations within textual data. Unlike traditional epidemiological studies that rely on structured datasets, text network analysis systematically explores unstructured textual information. This methodology is particularly well-suited for addressing the research gap in understanding the relationships among various COVID-19 risk factors, as it enables the detection of hidden connections and emerging trends within vast literature [6].
TNA differs from other computational methods, such as machine learning and natural language processing (NLP), in several ways. Machine learning techniques typically require labeled datasets for supervised training or employ unsupervised clustering algorithms to categorize data, often necessitating large-scale training datasets. NLP, on the other hand, is focused on processing and extracting meaning from text but may lack the ability to systematically map relationships between key concepts over time. In contrast, TNA constructs networks of semantic relationships between key terms, allowing researchers to visualize knowledge structures, detect thematic shifts, and track the evolution of scientific discourse [7].
Traditional epidemiological models primarily rely on structured datasets and predefined variables, which may limit their ability to capture complex interconnections and dynamic research trends. In contrast, TNA enables the systematic exploration of unstructured textual data, allowing researchers to uncover emerging themes, detect hidden relationships, and track the evolution of scientific discourse over time. Unlike static epidemiological models, TNA can continuously adapt to new research developments and identify unexpected associations between risk factors [8].
A key advantage of TNA is its ability to integrate diverse information sources, including academic literature, social media, and public health reports, to uncover meaningful relationships and emerging trends [9]. For example, during the early stages of the pandemic, social media served as a critical channel for disseminating public health information yet also contributed to the spread of misinformation. TNA enables researchers to systematically analyze and contextualize such data, distinguishing between reliable findings and misleading narratives [10].
Previous studies have often examined COVID-19 risk factors in isolation, lacking a holistic perspective on how different determinants interact within the broader research landscape. Additionally, many studies struggled to capture dynamic research shifts, as they relied on static datasets. By employing TNA, this study provides a comprehensive, data-driven synthesis of risk factor interactions over time, bridging these gaps and offering new insights into the evolving research landscape.
Recognizing the importance of understanding COVID-19 risk factors and their interconnections, this study employs text network analysis to investigate relationships among various disease-associated determinants. Specifically, the study aims (1) to identify key keywords in studies related to risk factors for severe COVID-19, (2) to analyze the relationships among keywords and classify subgroups based on network clusters, and (3) to examine the temporal research trends in studies related to severe COVID-19 risk factors.
Through this approach, this study seeks to provide a comprehensive and data-driven synthesis of risk factor interactions over time. By leveraging text network analysis, this research aims to bridge gaps in existing knowledge, offering insights that can inform public health strategies, policy decisions, and pandemic preparedness efforts.

2. Materials and Methods

This quantitative content analysis used text network analysis to extract key keywords related to severe COVID-19 risk factors, classify network-based subgroups, and identify research trends over time.

2.1. Search Strategy

Keywords for data collection were designed using a combination of natural language and MeSH (Medical Subject Heading) terms. Keywords included ‘COVID-19’, ‘SARS-CoV-2’, ‘2019-nCoV’, ‘risk’, ‘risk factor’, ‘severe’, ‘critical’, ‘severity’, ‘intensive care unit’, ‘respiratory failure’, and ‘fatal’ (Table A1). A literature search was conducted across four major academic databases: PubMed, Scopus, Web of Science, and EMBASE, to ensure comprehensive coverage of peer-reviewed studies. Boolean operators (“AND” and “OR”) were applied to construct the search queries. Specifically, “OR” was used to combine synonyms and related terms (e.g., “COVID-19” OR “SARS-CoV-2” OR “2019-nCoV”), while “AND” was used to refine searches by including key concepts (e.g., “COVID-19” AND “risk factor” AND “severe”). The final search queries were tailored to the syntax of each database. The search was limited to articles published in English and indexed in peer-reviewed journals, with a publication period from January 2020 to December 2021. To ensure transparency, a PRISMA flow diagram (Figure 1) was included to illustrate the article selection process.

2.2. Inclusion and Exclusion Criteria

A total of 42,900 articles were retrieved from the databases. After removing 15,161 duplicates, 27,739 articles were screened based on their titles and abstracts. Inclusion criteria were as follows: (1) articles published between January 2020 and December 2021; (2) studies on COVID-19 risk factors related to disease severity and transmission; (3) peer-reviewed publications in English; and (4) articles providing relevant epidemiological or clinical data. Exclusion criteria were as follows: (1) non-peer-reviewed papers, preprints, and opinions; (2) articles without abstracts or full-text availability; (3) studies involving non-human subjects (e.g., mice, cats, dogs, gorillas); and (4) research focusing on unrelated topics such as MERS or information security. Two independent reviewers, a researcher and a nursing professor, screened the articles and ultimately selected 22,628 articles for data analysis.

2.3. Data Extraction and Analysis

Data extraction focused on keyword identification, cleaning, statistical validation, and visualization. The following steps were performed:
(1)
Keyword Extraction and Cleaning
  • Keywords were extracted from the titles, abstracts, and keywords of the selected articles using Python 3.9, Natural Language Toolkit (NLTK) 3.6.7, and Text Rank algorithm.
  • Standardization was applied to account for variations in capitalization, pluralization, abbreviations, and special characters.
  • Synonyms were consolidated into single representative terms, ensuring consistency across the dataset.
(2)
Keyword Analysis and Visualization
  • Key keywords were analyzed using term frequency analysis and Term Frequency-Inverse Document Frequency (TF-IDF) with Python’s Sklearn module (Scikit-learn 0.24.2).
  • Results were visualized using Gephi 0.9.2, a widely used open-source tool for network analysis.
(3)
Clustering and Network Classification
  • Clusters were identified using modularity-based algorithms and PageRank centrality measures in Gephi.
  • Nodes with low similarity were filtered to improve clustering accuracy.
  • The Jaccard similarity coefficient threshold was set at 0.065 to exclude weak associations. The threshold (0.065) was determined based on both heuristic analysis and empirical validation. Following prior research [11], network visualization was used to assess optimal threshold selection. Additionally, multiple threshold values (0.05, 0.06, 0.07) were tested to balance network density and meaningful keyword relationships. The threshold of 0.065 was selected as it minimized noise while retaining key associations.
(4)
Temporal Trend Analysis
  • Temporal trends were analyzed by computing monthly similarity indices based on frequency matrices and Jaccard coefficients.
  • Cut-off points were determined by identifying peaks and troughs in similarity trends using statistical methods, including moving averages and Z-scores, to ensure objective detection.
  • Four distinct time intervals were identified, highlighting emerging keywords in each period.
This methodology provides a systematic approach to understanding the evolving landscape of severe COVID-19 risk factors, ensuring a data-driven framework for public health insights and policymaking.

3. Results

3.1. Characteristics of Severe COVID-19 Risk Factor Studies and Key Keywords

The collected studies on severe COVID-19 risk factors included articles published in international and domestic journals between January 2020 and December 2021. A total of 22,628 studies were analyzed. Monthly publication trends showed a rapid increase, starting with 54 studies in January 2020 and peaking at 895 in May 2020. Approximately 1000 studies were published monthly until October 2021, after which the number decreased (Figure 2).
The surge in early 2020 likely reflects the global research response to COVID-19. The peak in May 2020 may correspond to the initial wave of studies focusing on early risk-factor identification and pandemic mitigation strategies. After October 2021, the decline in publications likely resulted from a research shift toward vaccine efficacy, long COVID, and post-pandemic recovery efforts. Figure 2 illustrates these trends, highlighting the evolving research priorities over time in response to global health events and policy changes.
The retrieved studies were published in 5410 journals, with the top 15–20 journals accounting for approximately 9.8% of all articles (Figure 3). The top 10 journals included PLOS ONE (2.04%), International Journal of Environmental Research and Public Health (1.27%), Cureus (1.16%), Scientific Reports (1.00%), and Journal of Clinical Medicine (0.90%).
Table 1 presents keyword frequency and PageRank centrality values. Frequently appearing keywords included ‘age’ (3224 times), ‘treatment’ (2934), ‘diabetes’ (1504), ‘hypertension’ (1230), and ‘obesity’ (1045). PageRank centrality identified influential keywords such as ‘non-invasive ventilation’, ‘IgG’, ‘hyperglycemia’, ‘hypertension’, and ‘diabetes.’ Keywords with both high frequency and centrality included ‘hypertension’, ‘diabetes’, and ‘age. A detailed list of keywords is provided in Table A2.

3.2. Network Analysis of Keywords

To examine structural trends in studies on severe COVID-19 risk factors, a text network analysis was conducted to visualize the knowledge structure. Using a PageRank algorithm analysis, 1492 keywords were identified. Applying a Jaccard similarity coefficient ≥0.065, the dataset was filtered to 346 nodes and 672 links, removing keywords with low frequency or weak connectivity. The final selected keywords represent core risk factors for severe COVID-19. Figure A1 presents a spring map visualization of the network.
A total of 21 clusters were identified and categorized into five major thematic groups: (1) biomedical, (2) occupational and environmental, (3) demographic, (4) health behavior, and (5) complication factors (Figure A2).
These clusters reflect key aspects of severe COVID-19 risk factors. For example, the biomedical cluster includes terms such as “cytokine storm” and “coagulopathy”, which are closely associated with severe disease progression. The demographic cluster highlights age-related risks, particularly among elderly populations. Similarly, the occupational and environmental cluster encompasses COVID-19 exposure risks in work environments.
While this cluster includes terms such as mouth and dentists, these are strongly linked to occupational hazards in healthcare settings. Studies have consistently identified dentists and other frontline workers as high-risk groups due to their frequent exposure to aerosol-generating procedures (AGPs). This underscores the importance of infection control measures and personal protective equipment (PPE) usage in these work environments.
As shown in Figure A3, Group 5 (complication factors) was further divided into seven subcategories based on complications affecting organ systems (e.g., cardiovascular, respiratory, and immune responses). The keywords for each group are summarized in Table 2, illustrating that the major risk factors for severe COVID-19 are multifaceted and interrelated. The clustering results provide a structured overview of the interconnections between various risk factors, offering insights into how different domains contribute to severe COVID-19 outcomes. These findings highlight the multifaceted nature of COVID-19 risk and the necessity for interdisciplinary approaches in pandemic research.

3.3. Temporal Trends of Severe COVID-19 Risk Factor Studies

Temporal trends were analyzed using frequency matrices and Jaccard similarity coefficients to identify keyword usage changes over time. Keywords were examined monthly for 24 months and segmented into four phases. Phase 1 (February–June 2020) included keywords appearing ≥10 times with ≥100 total occurrences. Phase 2 (July–December 2020) included keywords with ≥10 occurrences and ≥50 total frequency. Phase 3 (January–March 2021) identified emerging keywords with ≥5 occurrences. Phase 4 (April–September 2021) highlighted keywords appearing ≥10 times with ≥20 total frequency (Figure 4).
Table 3 shows keyword frequencies by phase, including terms such as ‘obesity’, ‘social distancing’, ‘dyspnea’, ‘psychological well-being’, ‘long COVID’, and ‘mRNA vaccine’. Detailed frequencies are in Table A3.

4. Discussion

4.1. Principal Findings

The rapid spread of COVID-19 in early 2020 led to an exponential rise in research on transmission, mortality, and risk factors. Identifying contributors to severe COVID-19 became a global priority, informing public health interventions and guiding future research. This study employed text network analysis to examine key concepts and structural relationships in studies published between January 2020 and December 2021, providing insights into the evolving knowledge landscape.
Our findings identified ‘age’ as the most frequently mentioned keyword, aligning with prior studies indicating that older adults are more vulnerable due to weakened immune function and chronic inflammation [12]. ‘Hypertension’ emerged as a central keyword with both high frequency and PageRank centrality, confirming its role as a predictor of severe outcomes [13]. These findings highlight the need for targeted interventions for high-risk groups, particularly older adults and patients with pre-existing conditions. Additionally, recent research suggests that metabolic risk factors, such as obesity, diabetes, and metabolic syndrome, present a greater risk for severe complications than individual diseases alone [14]. This underscores the importance of a multidimensional approach to addressing complex risk factors. Some studies suggest that metabolic factors act as independent risk factors for severe COVID-19, while others indicate that their impact is mediated through hypertension and systemic inflammation [15]. This suggests the need for further research using causal modeling techniques to disentangle these interrelated pathways.
‘Non-invasive ventilation (NIV)’ exhibited high PageRank centrality despite lower frequency, indicating strong connections to other risk factors. However, many studies analyzing NIV use were conducted in hospital settings, which could introduce selection bias. The frequency of NIV use in severe COVID-19 cases may reflect institutional protocols rather than universal best practices [16]. Further investigation is needed to determine the optimal use of NIV across different patient populations and healthcare settings.

4.2. Network and Cluster Analysis

Network analysis identified five primary thematic clusters: biomedical, occupational, demographic, behavioral, and complication-related factors. The biomedical cluster featured terms such as ‘coagulopathy’, ‘hyperglycemia’, and ‘rheumatoid arthritis’, reinforcing the significance of underlying medical conditions. Consistent with previous research, coagulopathy was associated with increased mortality risk, highlighting the need for close monitoring of coagulation markers [17].
Occupational and environmental clusters focused on healthcare workers and long-term care facilities, underscoring occupational risks related to aerosol-generating procedures and inadequate protective equipment [18]. These findings support enhanced workplace protections for healthcare workers and vulnerable populations.
The demographic cluster emphasized ‘age’, ‘obesity’, and ‘race’, reflecting disparities in COVID-19 outcomes. Higher infection and mortality rates among Black and Hispanic populations have been widely documented, but the underlying causes of these disparities are complex [19]. Such disparities may arise from a combination of biological factors, socioeconomic conditions, and healthcare accessibility issues. Understanding the root causes of these disparities is crucial for developing equitable public health interventions. To effectively reduce racial and ethnic health disparities, a multi-faceted approach is required, which includes the following: Reducing socioeconomic inequalities through policies aimed at improving financial security, employment opportunities, and housing conditions. Enhancing healthcare access by addressing systemic inequities in insurance coverage and expanding medical services in underserved communities. Eliminating cultural and linguistic barriers to ensure equitable communication of health information and medical guidance. By implementing these strategies, public health initiatives can more effectively mitigate COVID-19 disparities and promote long-term health equity.
Behavioral clusters included ‘vaccine hesitancy’ and ‘alcohol consumption’, underscoring modifiable risk factors. Vaccine hesitancy remains a major barrier to herd immunity and outbreak control [19,20,21], necessitating public health campaigns to improve vaccine acceptance. Additionally, lifestyle factors such as smoking and alcohol consumption compromise immune function, increasing the risk of severe COVID-19. Smokers are 2–14 times more likely to develop severe cases than non-smokers, reinforcing the need for smoking cessation and alcohol reduction programs [22,23,24,25].

4.3. Inter-Cluster Relationships

This study highlights the interconnected nature of different clusters. Biomedical factors such as hypertension and obesity were closely linked to behavioral risk factors, including diet and physical inactivity. Similarly, occupational exposure correlated with demographic factors, as older adults and minority groups were more likely to work in high-risk frontline positions. Understanding these inter-cluster relationships is crucial for designing holistic public health strategies that address multiple interacting risk factors rather than isolated variables.
This study underscores the importance of a comprehensive approach to mitigating severe COVID-19 outcomes. By leveraging text network analysis, this study identified key research themes and their interconnections, offering valuable insights for future public health interventions and policymaking. Unlike traditional epidemiological models that analyze individual risk factors separately, our findings highlight the need for interdisciplinary approaches that integrate biomedical, social, and behavioral determinants to effectively mitigate severe COVID-19 outcomes.

4.4. Temporal Trends

Temporal analysis divided research trends into four phases:
Phase 1 (February–June 2020): Focused on early pandemic responses, including social distancing and transmission pathways [26].
Phase 2 (July–December 2020): As the pandemic progressed, research priorities shifted toward understanding population-specific vulnerabilities, including racial and socioeconomic disparities in infection rates and disease severity. During this period, the prolonged impact of lockdowns and healthcare system strain also contributed to increased interest in mental health challenges associated with pandemic stressors [27].
Phase 3 (January–March 2021): With the emergence of long-term effects of COVID-19, studies began to explore long COVID symptoms, post-viral syndromes, and their sociodemographic correlations [28].
Phase 4 (April–September 2021): Research efforts were increasingly directed toward vaccine development, public vaccination strategies, and the impact of emerging viral variants [29].
This progression reflects the evolving nature of research priorities in response to pandemic challenges, transitioning from immediate containment strategies to long-term health consequences and public health preparedness.

4.5. Strengths and Limitations

A key strength of this study is the use of advanced text network analysis, enabling a comprehensive evaluation of large-scale textual data. This approach provided insights into both established and emerging trends, supporting data-driven decision-making.
However, several limitations should be acknowledged. This study relied exclusively on English-language publications, introducing selection bias and limiting generalizability. The exclusion of non-peer-reviewed studies may have resulted in publication bias, omitting relevant but unpublished findings. Additionally, text network analysis has inherent limitations, including potential keyword bias, as term selection influences network structure. Temporal bias may also exist due to publication delays, potentially underrepresenting emerging risk factors. Furthermore, this study primarily utilized keyword frequency analysis and network-based methods, which identify associations between risk factors and severe COVID-19 outcomes but do not establish causal relationships. While the network analysis provides valuable insights into relational structures and co-occurrence patterns, it does not infer causality or determine the direct impact of specific risk factors. As a result, the findings should be interpreted as indicative of correlations rather than definitive causal links. To enhance the robustness of future research, additional statistical validation techniques (e.g., regression analysis, time-series modeling) and epidemiological modeling approaches (e.g., cohort studies, causal inference models, structural equation modeling) should be incorporated. These methods would help differentiate associative relationships from causal mechanisms, providing stronger empirical evidence for risk factor significance.

4.6. Implications and Future Directions

Findings from this study emphasize the need for interdisciplinary approaches to COVID-19 risk factors. While this study highlights key research themes, it is essential to translate these insights into clear and actionable public health strategies to improve pandemic preparedness.
Although COVID-19 is no longer a newly emerging crisis, its long-term effects—including post-infection complications, evolving variants, and pandemic-induced health disparities—continue to impact healthcare systems worldwide. The need to manage long COVID, chronic disease exacerbation, and the integration of pandemic lessons into future outbreak preparedness underscores the relevance of continued research in this field.
One of the critical aspects of pandemic response is ensuring that high-risk populations receive targeted interventions. Older adults, individuals with hypertension, and those with metabolic syndrome are particularly vulnerable to severe outcomes, necessitating tailored preventive measures and medical management strategies. In addition, efforts to expand healthcare access are crucial in mitigating disparities faced by vulnerable demographic groups who often experience systemic barriers to medical care.
Guidance on the appropriate use of non-invasive ventilation (NIV) is another area that requires refinement. Evidence-based guidelines should be established to ensure that NIV is utilized effectively, minimizing unnecessary intubations while optimizing respiratory support. Similarly, the psychological effects of lockdowns, economic distress, and post-infection trauma must be addressed through stronger mental health support systems integrated into pandemic response efforts.
Vaccine acceptance remains a major challenge in public health. Targeted communication strategies that address misinformation and vaccine hesitancy are essential in ensuring widespread immunization coverage. Effective campaigns should focus on culturally appropriate messaging and trust-building within communities.
Beyond these immediate public health measures, future research should incorporate statistical and epidemiological methodologies to strengthen the validity of findings derived from text network analysis. The application of regression models, time-series analysis, and epidemiological modeling—such as cohort studies, causal inference models, and structural equation modeling—would enhance causal inference and improve the robustness of risk factor identification.
As pandemics continue to evolve, integrating diverse analytical approaches will be crucial in shaping effective public health strategies. This study provides a comprehensive analytical framework that can be adapted for future infectious disease outbreaks, reinforcing data-driven decision-making in global health policy.

5. Conclusions

This study demonstrates the utility of the text network analysis in mapping knowledge structures and identifying trends in severe COVID-19 risk factors. The insights gained can inform targeted public health interventions, support data-driven policy development, and enhance pandemic preparedness. Specifically, our findings can help policymakers develop risk stratification models to identify high-risk populations, optimize vaccine distribution strategies, and improve early warning systems for emerging infectious diseases. Furthermore, the application of the text network analysis extends beyond COVID-19, offering a scalable approach for analyzing epidemiological data in future outbreaks. By leveraging such data-driven methodologies, decision-makers can implement more effective and proactive health strategies.

Author Contributions

Conceptualization: S.-K.L. and M.-A.K.; data curation: M.-A.K.; funding acquisition: S.-K.L.; investigation: M.-A.K.; methodology: S.-K.L. and M.-A.K.; project administration: S.-K.L.; software: M.-A.K.; supervision: S.-K.L.; validation: S.-K.L. and M.-A.K.; visualization: M.-A.K.; writing—original draft: M.-A.K.; writing—review and editing: S.-K.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), grant number 2021R1A2C2095271.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by Keimyung University’s Ethics Committee (IRB No. 40525-202203-HR-003-01; 15 March 2022).

Informed Consent Statement

Patient consent was waived because existing data or documents were used instead of directly engaging with the subjects.

Data Availability Statement

The data from this study are available upon reasonable request from the corresponding author.

Acknowledgments

This study is partially based on the first author’s doctoral dissertation completed at Keimyung University. However, significant modifications and expansions have been made, including additional analyses, updated literature, and refined methodologies to enhance its scientific contribution. The authors would like to express their gratitude to Keimyung University for its academic support during the doctoral research.

Conflicts of Interest

The authors declare no conflicts of interest. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
CK-MB Creatine Kinase-MB
COPD Chronic Obstructive Pulmonary Disease
COVID-19Coronavirus Disease 2019
IgGImmunoglobulin G
IgM Immunoglobulin M
IL-6Interleukin-6
NIVNon-Invasive Ventilation
SARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2
TF-IDFTerm Frequency–Inverse Document Frequency

Appendix A

Table A1. Literature search results.
Table A1. Literature search results.
DatabaseQuery DetailedNumber of Literature
PubMed((COVID-19 OR SARS-CoV-2 OR 2019-nCoV OR 2019-Novel Coronavirus OR COVID OR COVID-2019 OR coronavirus-disease-2019 OR severe-acute-respiratory-syndrome-coronavirus-2 [Title/Abstract]) AND (risk[Title/Abstract] OR risk factor[Title/Abstract] OR predict[Title/Abstract]) AND (severe[Title/Abstract] OR critical[Title/Abstract] OR ICU care[Title/Abstract] OR mechanical ventilation[Title/Abstract] OR intensive care unit[Title/Abstract] OR severity[Title/Abstract] OR respiratory failure[Title/Abstract] OR fatal[Title/Abstract]))17,674
CINAHL(COVID-19 OR SARS-CoV-2 OR 2019-nCoV OR 2019-Novel Coronavirus OR COVID OR COVID-2019 OR coronavirus disease-2019 OR severe-acute-respiratory-syndrome-coronavirus-2) AND (risk OR risk factor OR predict) AND (severe OR critical OR ICU care OR mechanical ventilation OR intensive care unit OR severity OR respiratory failure OR fatal)4367
EMBASE‘coronavirus disease 2019′:ab,ti AND (‘risk factor’:ab,ti OR risk:ab,ti) AND (‘disease severity’:ab,ti OR ‘intensive care’:ab,ti OR ‘intensive care unit’:ab,ti OR ‘artificial ventilation’:ab,ti OR ‘respiratory failure’:ab,ti OR fatality:ab,ti)1886
WoS(COVID-19 OR SARS-CoV-2 OR 2019-nCoV OR 2019-Novel Coronavirus OR COVID OR COVID-2019 OR coronavirus disease-2019 OR severe-acute-respiratory-syndrome-coronavirus-2) AND (risk OR risk factor OR predict) AND (severe OR critical OR ICU care OR mechanical ventilation OR intensive care unit OR severity OR respiratory failure OR fatal)18,973
Table A2. Keywords with the highest frequency of appearance.
Table A2. Keywords with the highest frequency of appearance.
RankKeywordFrequencyPageRank CentralityRankKeywordFrequencyPageRank Centrality
1Age32240.00113626Multiorgan failure2340.000272
2Treatment29340.00091127Asymptomatic2290.000576
3Diabetes15040.00119128Vitamin D2140.000961
4Hypertension12300.00123229Virus transmission1890.000343
5Obesity10450.00073230Anticoagulation1800.000866
6Healthcare workers9600.0006231Mild cases1650.000211
7Sex9410.00057632America1600.000569
8Mean age7670.00066533COVID-19 treatment1520.000281
9C-reactive protein5960.00086534Convalescent plasma1480.001066
10Mental health5430.00088735IgM1420.001007
11Social distancing4490.00020336Platelet1420.000565
12Cardiovascular disease4280.00068637Nasopharyngeal swab1400.000631
13IgG4280.0014338Cardiovascular system1340.000943
14IL-64150.00096139Immunosuppressant1330.000421
15Cytokine storm3980.00057340Coronary heart disease1320.000446
16COVID-19 vaccine3600.00121741Hyperglycemia1280.001327
17Invasive mechanical ventilation3550.00029542Reverse transcription PCR1260.000377
18Dyspnea3220.00046543Rheumatic disease1260.000924
19COVID-19 transmission3190.00040344Non-invasive ventilation1240.001531
20COVID-19 vaccination3190.00091145Glucocorticoid1160.00092
21Lactate dehydrogenase2850.00100346Endotracheal intubation1150.000567
22Acute kidney injury2730.00077647Chloroquine1130.00066
23Tocilizumab2580.00054948Cancer care1080.000854
24Remdesivir2570.00101249Vitamin D deficiency1080.000574
25Heart failure2350.00094750Aerosol-generating procedures1070.001079
51CT scan1070.00035176chest CT840.001138
52preterm birth1070.00128377dentist840.001023
53physical activity1040.00052578healthy controls840.000648
54Australian1030.00066879myocardial infarction840.000427
55prone positioning1020.00124380laboratory markers830.000251
56chronic lung disease1000.00020681patient health questionnaire-9820.002146
57secondary infection1000.00085782post-traumatic stress disorder820.000686
58RT-PCR testing990.0003183radiotherapy820.000903
59females980.00033784antibody response810.001636
60healthy individuals970.00038485coagulopathy810.001146
61sociodemographic factors970.00034886European society810.001098
62hemoglobin960.00081187renal failure810.000399
63hemodialysis950.00042288viral pneumonia810.00028
64white blood cell count950.00132789mechanically ventilated patients800.000509
65neutrophil count930.00107290pregnant patients800.000871
66multisystem inflammatory syndrome920.00064391antiviral therapy790.000343
67socioeconomic status920.00064192inflammatory bowel diseases790.000647
68symptomatic COVID-19920.00056593HIV infection780.000598
69corticosteroids900.00050994cesarean section770.001697
70Switzerland880.00039395innate immunity770.000648
71surgeon860.00144796propensity score770.000636
72beneficial effect850.00045597virus infection770.000639
73elective surgery850.0010298endothelial cells760.000272
74receiver operating characteristic curve850.00076899most common symptom760.000351
75autoimmune disease840.000616100vasopressor760.000295
101white760.001528126demographic information650.000384
102renin-angiotensin system750.00149127Denmark650.000808
103standard care740.001171128herd immunity650.000386
104lung disease730.000365129immunomodulators650.000949
105SARS-CoV-2 spike protein730.00097130neutrophil-to-lymphocyte ratio650.000509
106ventilatory support730.00032131alcohol consumption640.001007
107chest radiography720.000638132chronic liver disease640.000581
108SARS-CoV-2 pneumonia720.000259133non-pharmaceutical interventions640.000854
109airway690.000514134smoking status640.000591
110D-dimer level690.000725135anti-SARS-CoV-2 antibodies630.000759
111thromboembolic complications690.000557136atrial fibrillation630.00037
112ACE2 receptor680.000268137belief630.001276
113genome680.00076138California630.000343
114long-term care facilities680.000932139contact tracing630.000564
115mRNA vaccine680.001323140occupation630.001077
116worry680.000817141oxygen support630.000319
117hematological malignancies670.001023142self-isolation630.000349
118influenza vaccination670.000821143transmissibility630.000271
119patient health670.001849144central nervous system620.001034
120ACE-2660.001213145methylprednisolone620.000563
121Bangladesh660.00029146oxidative stress620.000713
122blood pressure660.001118147perceived stress620.000861
123confidence660.000745148psychological symptoms620.001323
124abdominal pain650.000988149relapse620.000413
125anticoagulation therapy650.001079150seroconversion620.00123
151critical disease610.000496176Hispanics590.001094
152dysregulation610.00051177IL-1590.001205
153IgA610.000667178investigator590.000704
154insomnia severity index610.001768179machine learning model590.000408
155insulin610.001046180perceived risk590.000321
156mental health outcomes610.000682181sequential organ failure assessment590.001008
157metabolism610.000494182supplementation590.001031
158mobility610.001083183acute coronary syndrome580.001673
159tobacco smoking610.001362184chest pain580.000251
160anorexia600.001089185conflict580.000566
161fibrosis600.00037186immune function580.000664
162home quarantine600.00043187preventive strategies580.000322
163hypoxemic respiratory failure600.000434188prothrombin time580.001617
164lymphocytopenia600.000542189rituximab580.001095
165males600.00028190TNF-alpha580.00094
166neutralizing antibodies600.000465191travel580.000554
167nosocomial transmission600.000269192water580.000605
168rheumatoid arthritis600.001324193alcohol570.001026
169vaccines600.000779194bacteria570.001565
170zinc600.001032195black race570.001431
171aerosolization590.001502196immune dysregulation570.000511
172bed590.0005197kidney transplant570.001297
173Delta590.00024198lesion570.00084
174feeling590.000414199positive test results570.000272
175healthcare resources590.000209200social determinants570.000525
Figure A1. Spring network map of severe COVID-19 risk factors.
Figure A1. Spring network map of severe COVID-19 risk factors.
Jcm 14 02084 g0a1
Figure A2. Clustering of severe COVID-19 risk factors: Groups 1–4.
Figure A2. Clustering of severe COVID-19 risk factors: Groups 1–4.
Jcm 14 02084 g0a2
Figure A3. Group 5: Complication factors.
Figure A3. Group 5: Complication factors.
Jcm 14 02084 g0a3
Table A3. Jaccard similarity values by month.
Table A3. Jaccard similarity values by month.
PhaseMonthSimilarity
12020.02.∼2020.03.0.187
2020.03.∼2020.04.0.244
2020.04.∼2020.05.0.429
2020.05.∼2020.06.0.676
2020.06.∼2020.07.0.637
22020.07.∼2020.08.0.660
2020.08.∼2020.09.0.650
2020.09.∼2020.10.0.695
2020.10.∼2020.11.0.662
2020.11.∼2020.12.0.676
2020.12.∼2021.01.0.603
32021.01.∼2021.02.0.697
2021.02.∼2021.03.0.677
2021.03.∼2021.04.0.655
42021.04.∼2021.05.0.679
2021.05.∼2021.06.0.695
2021.06.∼2021.07.0.698
2021.07.∼2021.08.0.690
2021.08.∼2021.09.0.697
2021.09.∼2021.10.0.687

References

  1. World Health Organization. Coronavirus Disease (COVID-19) Pandemic. 2020. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed on 12 February 2022).
  2. Centers for Disease Control and Prevention. COVID-19 Overview and Infection Prevention and Control Priorities in Non-U.S. Healthcare Settings. Available online: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/hcp/non-us-settings/overview/index.html (accessed on 12 February 2022).
  3. Dong, E.; Du, H.; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020, 20, 533–534. [Google Scholar] [CrossRef]
  4. Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef]
  5. Wang, C.; Horby, P.W.; Hayden, F.G.; Gao, G.F. A novel coronavirus outbreak of global health concern. Lancet 2020, 395, 470–473. [Google Scholar] [CrossRef]
  6. Eysenbach, G. How to fight an infodemic: The four pillars of infodemic management. J. Med. Internet Res. 2020, 22, e21820. [Google Scholar] [CrossRef]
  7. Lodhwal, V.; Choudhary, G. Survey Paper: Automatic Title Generation for Text with RNN and Pre-trained Transformer Language Model. Int. J. Res. Appl. Sci. Eng. Technol. 2023, 11, 2117–2124. [Google Scholar] [CrossRef]
  8. Dritsas, E.; Trigka, M. Exploring the intersection of machine learning and big data: A survey. Mach. Learn. Knowl. Extr. 2025, 7, 13. [Google Scholar] [CrossRef]
  9. Park, S.; Park, J. Identifying the knowledge structure and trends of outreach in public health care: A text network analysis and topic modeling. Int. J. Environ. Res. Public Health 2021, 18, 9309. [Google Scholar] [CrossRef]
  10. Kim, H.J.; Bae, S.H.; Park, J.H. Research trends on cancer-related cognitive impairment in patients with non-central nervous system cancer: Text network analysis and topic modeling. J. Korean Acad. Fundam. Nurs. 2023, 30, 313–324. [Google Scholar] [CrossRef]
  11. Lee, S.S. Analytical Study on the Relationship between Centralities of Research Networks and Research Performances. J. Korean Libr. Inf. Sci. Soc. 2013, 44, 405–428. [Google Scholar] [CrossRef]
  12. Zhang, H.; Wu, Y.; He, Y.; Liu, X.; Liu, M.; Tang, Y.; Xu, S.; Wang, M.; Wang, W.; Liang, G.; et al. Age-related risk factors and complications of patients with COVID-19: A population-based retrospective study. Front. Med. 2022, 8, 757459. [Google Scholar] [CrossRef]
  13. Du, Y.; Zhou, N.; Zha, W.; Lv, Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 745–755. [Google Scholar] [CrossRef]
  14. Fan, X.; Han, J.; Zhao, E.; Fang, J.; Wang, D.; Cheng, Y.; Shi, Y.; Wang, Z.; Yao, Z.; Lu, P.; et al. The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: A population-based study. Cell Metab. 2023, 35, 585–600.e5. [Google Scholar] [CrossRef] [PubMed]
  15. Wu, S.; Zhou, K.; Misra-Hebert, A.; Bena, J. Impact of metabolic syndrome on severity of COVID-19 illness. Metab. Syndr. Relat. Disord. 2022, 20, 191–249. [Google Scholar] [CrossRef]
  16. Ramirez, G.A.; Bozzolo, E.P.; Gobbi, A.; Castelli, E.; Centurioni, C.; Di Meo, M.; Della Torre, E.; Di Scala, F.; Morgillo, A.; Marinosci, A.; et al. Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19. Panminerva Med. 2022, 64, 506–516. [Google Scholar] [CrossRef] [PubMed]
  17. Castro, R.A.; Frishman, W.H. Thrombotic complications of COVID-19 infection: A review. Cardiol. Rev. 2021, 29, 43–47. [Google Scholar] [CrossRef] [PubMed]
  18. Galanis, P.; Vraka, I.; Fragkou, D.; Bilali, A.; Kaitelidou, D. Impact of personal protective equipment use on health care workers’ physical health during the COVID-19 pandemic: A systematic review and meta-analysis. Am. J. Infect. Control 2021, 49, 1305–1315. [Google Scholar] [CrossRef]
  19. Mackey, K.; Ayers, C.K.; Kondo, K.K.; Saha, S.; Advani, S.M.; Young, S.; Spencer, H.; Rusek, M.; Anderson, J.; Veazie, S.; et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: A systematic review. Ann. Intern. Med. 2021, 174, 362–373. [Google Scholar] [CrossRef]
  20. Schoch-Spana, M.; Brunson, E.K.; Long, R.; Ruth, A.; Ravi, S.J.; Trotochaud, M.; Borio, L.; Brewer, J.; Buccina, J.; Connell, N.; et al. The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine 2021, 39, 6004–6012. [Google Scholar] [CrossRef]
  21. Mohammed, I.; Nauman, A.; Paul, P.; Ganesan, S.; Chen, K.-H.; Jalil, S.M.S.; Jaouni, S.H.; Kawas, H.; Khan, W.A.; Vattoth, A.L.; et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum. Vaccin. Immunother. 2022, 18, 2027160. [Google Scholar] [CrossRef]
  22. Chodkiewicz, J.; Talarowska, M.; Miniszewska, J.; Nawrocka, N.; Bilinski, P. Alcohol consumption reported during the COVID-19 pandemic: The initial stage. Int. J. Environ. Res. Public Health 2020, 17, 4677. [Google Scholar] [CrossRef]
  23. Guan, W.-J.; Ni, Z.-Y.; Hu, Y.; Liang, W.-H.; Ou, C.-Q.; He, J.-X.; Liu, L.; Shan, H.; Lei, C.-L.; Hui, D.S.C.; et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, R.; Han, H.; Liu, F.; Lv, Z.; Wu, K.; Liu, Y.; Feng, Y.; Zhu, C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin. Chim. Acta 2020, 505, 172–175. [Google Scholar] [CrossRef]
  25. Zhong, R.; Chen, L.; Zhang, Q.; Li, B.; Qiu, Y.; Wang, W.; Tan, D.; Zou, Y. Which factors—Smoking, drinking alcohol, betel quid chewing, or underlying diseases—Are more likely to influence the severity of COVID-19? Front. Physiol. 2021, 11, 623498. [Google Scholar] [CrossRef]
  26. Zhang, L.; Zhao, W.; Sun, B.; Huang, Y.; Glänzel, W. How scientific research reacts to international public health emergencies: A global analysis of response patterns. Scientometrics 2020, 124, 747–773. [Google Scholar] [CrossRef]
  27. Thomeer, M.B.; Moody, M.D.; Yahirun, J. Racial and ethnic disparities in mental health and mental health care during the COVID-19 pandemic. J. Racial Ethn. Health Disparities 2023, 10, 961–976. [Google Scholar] [CrossRef]
  28. Crook, H.; Raza, S.; Nowell, J.; Young, M.; Edison, P. Long covid—Mechanisms, risk factors, and management. BMJ 2021, 374, n1648. [Google Scholar] [CrossRef]
  29. Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Pérez Marc, G.; Moreira, E.D.; Zerbini, C.; et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 2020, 383, 2603–2615. [Google Scholar] [CrossRef]
Figure 1. PRISMA flow diagram of article selection process.
Figure 1. PRISMA flow diagram of article selection process.
Jcm 14 02084 g001
Figure 2. Monthly publications of severe COVID-19 risk factor studies.
Figure 2. Monthly publications of severe COVID-19 risk factor studies.
Jcm 14 02084 g002
Figure 3. Journal distribution of search articles.
Figure 3. Journal distribution of search articles.
Jcm 14 02084 g003
Figure 4. Phase setting by Jaccard similarity.
Figure 4. Phase setting by Jaccard similarity.
Jcm 14 02084 g004
Table 1. Keywords list with the highest appearance frequency.
Table 1. Keywords list with the highest appearance frequency.
RankKeywordFrequencyPageRank CentralityRankFrequencyFrequencyPage Rank Centrality
1Age32240.00113626Multiorgan failure2340.000272
2Treatment29340.00091127Asymptomatic2290.000576
3Diabetes15040.00119128Vitamin D2140.000961
4Hypertension12300.00123229Virus transmission1890.000343
5Obesity10450.00073230Anticoagulation1800.000866
6Healthcare workers9600.0006231Mild cases1650.000211
7Sex9410.00057632America1600.000569
8Mean age7670.00066533COVID-19 treatment1520.000281
9C-reactive protein5960.00086534Convalescent plasma1480.001066
10Mental health5430.00088735IgM1420.001007
11Social distancing4490.00020336Platelet1420.000565
12Cardiovascular disease4280.00068637Nasopharyngeal swab1400.000631
13IgG4280.0014338Cardiovascular system1340.000943
14IL-64150.00096139Immunosuppressant1330.000421
15Cytokine storm3980.00057340Coronary heart disease1320.000446
16COVID-19 vaccine3600.00121741Hyperglycemia1280.001327
17Invasive mechanical ventilation3550.00029542Reverse transcription PCR1260.000377
18Dyspnea3220.00046543Rheumatic disease1260.000924
19COVID-19 transmission3190.00040344Non-invasive ventilation1240.001531
20COVID-19 vaccination3190.00091145Glucocorticoid1160.00092
21Lactate dehydrogenase2850.00100346Endotracheal intubation1150.000567
22Acute kidney injury2730.00077647Chloroquine1130.00066
23Tocilizumab2580.00054948Cancer care1080.000854
24Remdesivir2570.00101249Vitamin D deficiency1080.000574
25Heart failure2350.00094750Aerosol-generating procedures1070.001079
Table 2. Main keywords list of groups.
Table 2. Main keywords list of groups.
GroupFactorsSubtopicKeywords
G1Biomedicine factors-thrombolysis, acute pulmonary embolism, hyperglycemia, rheumatoid arthritis, kidney transplant, hemostasis, insulin resistance, transplant, major bleeding, liver transplant recipients, coagulopathy, low-molecular-weight heparin, coagulation abnormalities, glucose, transplant recipients, COVID-19-associated coagulopathy, rheumatic disease
G2Occupational and
environmental factors
-oral cavity, surgical masks, personal protective equipment use, staff members, dental practice, mouth, nasal, residents, aerosol-generating procedures, dentist, otolaryngologist, long-term care facilities, nursing home, nursing home residents
G3Demographic factors-non-hispanic black, racial disparities, white, black race, Latino, hypertension, diabetes, age, hospital, mortality, COVID-19 infection, COVID-19 patient, COVID-19 pandemic, health equity, obesity, mean age, sex
G4Health behavior
factors
-Moderna, vaccine hesitancy, vaccine acceptance, tobacco smoking, mRNA vaccine, COVID-19 vaccine, allergic reactions, smoking cessation, epitope, cigarette smoking, nicotine, COPD patients, immunogenicity, current smokers, lung function, vaccine safety, alcohol, alcohol consumption
G5Complication factorsC1 (Immunologic)tumor necrosis factor, coagulation system, hyperinflammatory state, IgG, macrophage, IL-1, IL-10, NK cells, IL-2, IL-6, B cells, cytokine storm
C2 (Psychiatric)Patient Health Questionnaire-9, Insomnia Severity Index, poverty, mental health symptoms, insomnia symptoms, sleep quality, psychological symptoms, generalized anxiety, psychological status, mental health issues
C3 (Respiratory)respiratory status, non-invasive ventilation, nasal cannula, room air, prone positioning, bronchoscopy, high-flow nasal cannula
C4 (Cardiac)cardiac biomarkers, acute coronary syndrome, acute myocardial injury, cardiac arrhythmias, heart failure, pre-existing cardiovascular disease, CK-MB
C5 (Neurologic)encephalitis, Guillain-Barre syndrome, seizure, neurological disorders, neurological symptoms
C6 (Gynecologic)cesarean section, neonatal outcomes, breast milk, preterm birth, adverse pregnancy outcomes, breastfeeding, maternal mortality
C7 (Secondary Infection)Candida, bacteria, Klebsiella, Staphylococcus, bacterial infections, coinfection
Table 3. The appearance frequencies of the keywords in each phase.
Table 3. The appearance frequencies of the keywords in each phase.
KeywordsPhase 1Phase 2Phase 3Phase 4
Obesity91320170464
Social distancing6714462176
Dyspnea4210056124
COVID-19 transmission398360137
Chloroquine32411525
Emergency department3010163159
America27552850
Radiotherapy26241121
Virus transmission22603572
Coronary heart disease22342551
Cancer care21391632
Dentist2128926
Perceived stress-131534
Psychological symptoms-131237
Hispanics-171626
Generalized anxiety-151024
Psychological well-being-10830
Health disparities-151113
Urea-15914
Common complication-14915
Deep venous thrombosis-131011
Black race121926
Critical disease1201426
Second wave1192990
Persistent symptoms-21022
Long COVID--621
Nationality--614
Mucormycosis-1632
Moderna-1544
First lockdown-1521
Risk and protective factors-2719
Anaphylaxis-2627
Blood parameters11912
Sociodemographic data-2810
mRNA vaccine-1463
Delta-1355
Bamlanivimab---35
Vaccine effectiveness-2227
New variants--326
Vaccination coverage--323
Vaccine acceptance-1319
Vaccination campaign-1318
Kidney replacement therapy13-17
Fungal infections12216
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kang, M.-A.; Lee, S.-K. Exploring Coronavirus Disease 2019 Risk Factors: A Text Network Analysis Approach. J. Clin. Med. 2025, 14, 2084. https://doi.org/10.3390/jcm14062084

AMA Style

Kang M-A, Lee S-K. Exploring Coronavirus Disease 2019 Risk Factors: A Text Network Analysis Approach. Journal of Clinical Medicine. 2025; 14(6):2084. https://doi.org/10.3390/jcm14062084

Chicago/Turabian Style

Kang, Min-Ah, and Soo-Kyoung Lee. 2025. "Exploring Coronavirus Disease 2019 Risk Factors: A Text Network Analysis Approach" Journal of Clinical Medicine 14, no. 6: 2084. https://doi.org/10.3390/jcm14062084

APA Style

Kang, M.-A., & Lee, S.-K. (2025). Exploring Coronavirus Disease 2019 Risk Factors: A Text Network Analysis Approach. Journal of Clinical Medicine, 14(6), 2084. https://doi.org/10.3390/jcm14062084

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop